Anne E. Lykkesfeldt
- Cancer Research top 2%
- Breast Cancer Treatment Studies 8
- Oncology top 2%
- HER2/EGFR in Cancer Research 29
- Cancer-related Molecular Pathways 8
- Cytokine Signaling Pathways and Interactions 8
- Cancer Cells and Metastasis 7
- Genetics top 1%
- Estrogen and related hormone effects 66
- Molecular Biology top 5%
- Toxicology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 11
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Per BriandChristina W. YdeAnne‐Vibeke LænkholmS. S. LarsenJan StenvangThomas FrogneMogens Winkel MadsenBirgitte Rasmussen
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Breast Cancer Research and Treatment (14 papers)Molecular and Cellular Endocrinology (7 papers)Acta Oncologica (7 papers)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Anne E. Lykkesfeldt
111 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 803
- Oncology 1.4k
- Genetics 1.4k
- Molecular Biology 1.8k
- Toxicology 68
Countries citing papers authored by Anne E. Lykkesfeldt
This map shows the geographic impact of Anne E. Lykkesfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Lykkesfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Lykkesfeldt more than expected).
Fields of papers citing papers by Anne E. Lykkesfeldt
This network shows the impact of papers produced by Anne E. Lykkesfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Lykkesfeldt. The network helps show where Anne E. Lykkesfeldt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne E. Lykkesfeldt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2017 | 16 | |
| 3 | 2016 | 53 | |
| 4 | 2015 | 21 | |
| 5 | 2014 | 8 | |
| 6 | 2013 | 61 | |
| 7 | 2012 | 18 | |
| 8 | 2012 | 48 | |
| 9 | 2012 | 7 | |
| 10 | 2011 | 3 | |
| 11 | 2010 | 70 | |
| 12 | 2009 | 25 | |
| 13 | 2009 | 60 | |
| 14 | 2008 | 2 | |
| 15 | 2006 | 82 | |
| 16 | 2005 | 70 | |
| 17 | 2003 | 38 | |
| 18 | 2001 | 22 | |
| 19 | 1994 | 39 | |
| 20 | 1992 | 16 |
About Anne E. Lykkesfeldt
Anne E. Lykkesfeldt is a scholar working on Genetics, Oncology and Cancer Research, having authored 111 papers that have together received 3.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (66 papers), HER2/EGFR in Cancer Research (29 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Advanced Breast Cancer Therapies (9 papers), Cancer-related Molecular Pathways (8 papers), Breast Cancer Treatment Studies (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (803 citations), Oncology (1.4k citations) and Genetics (1.4k citations). Anne E. Lykkesfeldt has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Per Briand, Christina W. Yde, Anne‐Vibeke Lænkholm, S. S. Larsen, Jan Stenvang, Thomas Frogne, Mogens Winkel Madsen, Birgitte Rasmussen, Katrine L. Henriksen and Bent Ejlertsen. Their work appears in journals such as Breast Cancer Research and Treatment, Molecular and Cellular Endocrinology, Acta Oncologica, British Journal of Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.